127 related articles for article (PubMed ID: 1284980)
1. Serum concentration of alpha-2-macroglobulin, alpha-1-antitrypsin and alpha-1-antichymotrypsin [correction of alpha-2-antichymotrypsin] in patients with Hodgkin's disease.
Dabrowska M; Kemona H; Prokopowicz J; Kiluk S
Mater Med Pol; 1992; 24(1):28-30. PubMed ID: 1284980
[TBL] [Abstract][Full Text] [Related]
2. Alpha 1-antitrypsin, alpha 1-antichymotrypsin and alpha 2-macroglobulin in human liver fluke (opisthorchiasis).
Changbumrung S; Migasena P; Supawan V; Buavatana T; Migasena S
Tropenmed Parasitol; 1982 Sep; 33(3):195-7. PubMed ID: 6182657
[TBL] [Abstract][Full Text] [Related]
3. Serum concentration of alpha-2-macroglobulin, alpha-1-antitrypsin and alpha-2-antichymotrypsin in patients with lung carcinoma.
Dabrowska M; Prokopowicz J; Kemona H; Kretowska J; Kiluk S; Gluszczak M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(6):817-23. PubMed ID: 2467852
[TBL] [Abstract][Full Text] [Related]
4. Serum concentration of alpha 1-antichymotrypsin is elevated in patients with senile dementia of the Alzheimer type.
Matsubara E; Amari M; Shoji M; Harigaya Y; Yamaguchi H; Okamoto K; Hirai S
Prog Clin Biol Res; 1989; 317():707-14. PubMed ID: 2690117
[TBL] [Abstract][Full Text] [Related]
5. Serum antithrombin III and alpha-2-antiplasmin concentrations in patients with Hodgkin's disease in the course of chemotherapy.
Dabrowska M; Kemona H; Prokopowicz J; Kretowska J; Kiluk S
Neoplasma; 1991; 38(3):249-52. PubMed ID: 1713303
[TBL] [Abstract][Full Text] [Related]
6. Interactions of alpha-1-antichymotrypsin, alpha-1-proteinase inhibitor, and alpha-2-macroglobulin with the fungal enzyme, seaprose.
Korzus E; Luisetti M; Travis J
Biol Chem Hoppe Seyler; 1994 May; 375(5):335-41. PubMed ID: 7521171
[TBL] [Abstract][Full Text] [Related]
7. Addition of purified prostate specific antigen to serum from female subjects: studies on the relative inhibition by alpha 2-macroglobulin and alpha 1-antichymotrypsin.
Chen Z; Komatsu K; Prestigiacomo A; Stamey TA
J Urol; 1996 Oct; 156(4):1357-63. PubMed ID: 8808871
[TBL] [Abstract][Full Text] [Related]
8. Serum alpha-1 antichymotrypsin is a possible growth inhibitor of Plasmodium falciparum.
Tharavanij S; Patarapotikul J; Supavan V; Schelp FP; Warrell MJ
Southeast Asian J Trop Med Public Health; 1983 Sep; 14(3):349-52. PubMed ID: 6197759
[TBL] [Abstract][Full Text] [Related]
9. Protease inhibitors in acute human pancreatitis. Correlation between biochemical changes and clinical course.
Lasson A; Ohlsson K
Scand J Gastroenterol; 1984 Sep; 19(6):779-86. PubMed ID: 6083596
[TBL] [Abstract][Full Text] [Related]
10. Serum concentration of alpha1-proteinase inhibitor and alpha2-macroglobulin correlates with late lumen loss following coronary stent implantation.
Ikari Y; Hashimoto H; Nakajima H; Hara K
J Thromb Haemost; 2003 Jan; 1(1):193-4. PubMed ID: 12871561
[No Abstract] [Full Text] [Related]
11. Serum protease inhibitors in opisthorchiasis, hepatoma, cholangiocarcinoma, and other liver diseases.
Changbumrung S; Migasena P; Supawan V; Juttijudata P; Buavatana T
Southeast Asian J Trop Med Public Health; 1988 Jun; 19(2):299-305. PubMed ID: 2465579
[TBL] [Abstract][Full Text] [Related]
12. Serum alpha-1-antitrypsin and alpha-1-antichymotrypsin after surgical treatment and during postoperative clinical course of human gastric cancer.
Bernacka K; Kuryliszyn-Moskal A; Klimiuk PA
Neoplasma; 1993; 40(2):111-6. PubMed ID: 7688868
[TBL] [Abstract][Full Text] [Related]
13. Activation of protein C and its distribution between its inhibitors, protein C inhibitor, alpha 1-antitrypsin and alpha 2-macroglobulin, in patients with disseminated intravascular coagulation.
Scully MF; Toh CH; Hoogendoorn H; Manuel RP; Nesheim ME; Solymoss S; Giles AR
Thromb Haemost; 1993 May; 69(5):448-53. PubMed ID: 7686692
[TBL] [Abstract][Full Text] [Related]
14. [Pi phenotypes of alpha-1-antitrypsin and antiproteases in meningococcal sepsis].
Ruiz C; Blanco Quirós A; Solís P; Alvarez Guisasola J; Sánchez Villares E
An Esp Pediatr; 1983 Oct; 19(4):268-78. PubMed ID: 6197915
[TBL] [Abstract][Full Text] [Related]
15. Protease inhibitor and gastric cancer.
Tsumoto S; Oyabu H; Kageyama T
Bull Osaka Med Sch; 1983 Jul; 29(1):18-26. PubMed ID: 6204707
[No Abstract] [Full Text] [Related]
16. Increased serum levels of alpha-2-macroglobulin in severe chronic airflow obstruction.
Pedersen JZ; Franck C
Eur J Respir Dis; 1986 Mar; 68(3):195-9. PubMed ID: 2422050
[TBL] [Abstract][Full Text] [Related]
17. [Activity of selected proteinase inhibitors in patients with disorders of lipid metabolism].
Kopieczna-Grzebieniak E; Drózdz M; Grabowska-Bochenek R; Piekarski M
Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):12-4. PubMed ID: 1384011
[TBL] [Abstract][Full Text] [Related]
18. [A study of antithrombin systems during heparin therapy].
Boneu B; Immaculato F; Sie P; Caranobe C; Chamontin B; Guittard J
Nouv Presse Med; 1982 Oct; 11(41):3043-6. PubMed ID: 6183640
[TBL] [Abstract][Full Text] [Related]
19. Proteases, antiproteases, and oxidants: pathways of tissue injury during inflammation.
Janoff A; Carp H
Monogr Pathol; 1982; (23):62-82. PubMed ID: 6181397
[No Abstract] [Full Text] [Related]
20. [Diagnostic value of determining endogenous proteinase inhibitors in cancer patients].
Shcherbak IG; Potashov LV; Levin AO; Kulikova AI; Sitkevich RV
Vopr Onkol; 1987; 33(3):22-6. PubMed ID: 2436380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
